Civic Science Times
From Scroll to Success: Exploring the Role of Science Communicators in Ozempic’s TikTok Triumph
In the past year, you can’t open any form of media without hearing about Ozempic — the “magic” weight loss drug initially approved for diabetes. Ozempic is polarizing to say the least. Some people are obsessed with it and praise its use from the rooftops. Others are angered that this drug is being advertised as a magical diet pill. Either way, the cultural impact, financial success, and scientific innovation of ozempic cannot be denied.
Ozempic was originally approved by the FDA in 2017 for patients with diabetes. In 2021, a similar drug called Wegovy was approved for weight loss. The popularity of these drugs skyrocketed so much that they are on the FDA shortage list. But how exactly did this happen and what are the implications of Ozempic’s success on researchers and science communicators? The success of Ozempic lies at the intersection of diet culture, celebrity influence, social media, and scientific innovation.
Read more on the Civic Science Times
I am a bioengineer and content creator. I have a B.S. in Biomedical Engineering from Virginia Commonwealth University and a Bioengineering PhD from the University of Maryland, College Park.
-
Civic Science Times2 weeks ago
Visualized: Massachusetts is no. 2 state with highest number of active public engagement with science grants from the NSF-AISL program
-
Civic Science Times1 week ago
Boston resident Kwasi Agbleke is working to expand access to biomedical research in Ghana and across Africa
-
Civic Science Times3 weeks ago
Resuming community science projects after a disaster
-
CivicSciTV - Questions of the Day2 weeks ago
Science communication in extended & virtual reality? Northeastern’s Eileen McGivney shares insights